These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 8650624)
41. Hypotony maculopathy in a patient with HLA-B27-associated uveitis. Roe R; Branco BC; Cunningham ET Ocul Immunol Inflamm; 2008; 16(3):107-8. PubMed ID: 18569798 [TBL] [Abstract][Full Text] [Related]
42. Ocular manifestations of HIV infection. Jabs DA Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695 [TBL] [Abstract][Full Text] [Related]
43. [Results of treating the residual manifestations of uveitis of rheumatic and rheumatoid etiology at a health resort (the town of Yevpatoriya)]. Mal'te NS; Gudiev AT Oftalmol Zh; 1989; (4):218-21. PubMed ID: 2797695 [TBL] [Abstract][Full Text] [Related]
44. Scleritis associated with rheumatoid arthritis and with other systemic immune-mediated diseases. Sainz de la Maza M; Foster CS; Jabbur NS Ophthalmology; 1994 Jul; 101(7):1281-6; discussion 1287-8. PubMed ID: 8035992 [TBL] [Abstract][Full Text] [Related]
45. Ocular diseases in patients with rheumatic diseases. Ausayakhun S; Louthrenoo W; Aupapong S J Med Assoc Thai; 2002 Aug; 85(8):855-62. PubMed ID: 12403205 [TBL] [Abstract][Full Text] [Related]
46. The emergency room in systemic rheumatic diseases. Slobodin G; Hussein A; Rozenbaum M; Rosner I Emerg Med J; 2006 Sep; 23(9):667-71. PubMed ID: 16921075 [TBL] [Abstract][Full Text] [Related]
47. Corneal and scleral involvement in inflammatory rheumatic disease: Rheumatologists and ophthalmologists exchanging views. Clavel G; Gabison E; Semerano L Joint Bone Spine; 2019 Nov; 86(6):699-705. PubMed ID: 30711694 [TBL] [Abstract][Full Text] [Related]
48. [Ocular manifestations of Rheumatic diseases]. Günther J; Max R; Lorenz HM Dtsch Med Wochenschr; 2021 Jul; 146(13-14):882-889. PubMed ID: 34256401 [TBL] [Abstract][Full Text] [Related]
49. Anatomic review and topographic diagnosis. Balcer LJ Ophthalmol Clin North Am; 2001 Mar; 14(1):1-21, vii. PubMed ID: 11370561 [TBL] [Abstract][Full Text] [Related]
50. Managing IBD outside the gut: ocular manifestations. Calvo P; Pablo L Dig Dis; 2013; 31(2):229-32. PubMed ID: 24030231 [TBL] [Abstract][Full Text] [Related]
54. Bilateral chorioretinopathy in child-onset systemic lupus erythematosus. Fischer WGG; Kaé TO; de Almeida R; de Oliveira Filho UL; Vilela MAP; Araujo DB Lupus; 2017 Sep; 26(10):1112-1114. PubMed ID: 27831536 [TBL] [Abstract][Full Text] [Related]
55. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Smith JR; Levinson RD; Holland GN; Jabs DA; Robinson MR; Whitcup SM; Rosenbaum JT Arthritis Rheum; 2001 Jun; 45(3):252-7. PubMed ID: 11409666 [TBL] [Abstract][Full Text] [Related]
56. [Skin changes in rheumatic diseases]. Dobrić I Reumatizam; 2005; 52(2):9-20. PubMed ID: 16689123 [TBL] [Abstract][Full Text] [Related]